KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Profit After Tax: 2010-2025

Historic Profit After Tax for Opko Health (OPK) over the last 16 years, with Sep 2025 value amounting to $21.6 million.

  • Opko Health's Profit After Tax fell 13.09% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$180.4 million, marking a year-over-year decrease of 34.89%. This contributed to the annual value of -$53.2 million for FY2024, which is 71.82% up from last year.
  • Opko Health's Profit After Tax amounted to $21.6 million in Q3 2025, which was up 114.57% from -$148.4 million recorded in Q2 2025.
  • Opko Health's Profit After Tax's 5-year high stood at $31.1 million during Q1 2021, with a 5-year trough of -$148.4 million in Q2 2025.
  • Its 3-year average for Profit After Tax is -$39.7 million, with a median of -$19.6 million in 2023.
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 152.56% in 2021, then crashed by 1,340.48% in 2025.
  • Over the past 5 years, Opko Health's Profit After Tax (Quarterly) stood at -$73.8 million in 2021, then declined by 15.53% to -$85.2 million in 2022, then grew by 22.00% to -$66.5 million in 2023, then soared by 121.10% to $14.0 million in 2024, then dropped by 13.09% to $21.6 million in 2025.
  • Its last three reported values are $21.6 million in Q3 2025, -$148.4 million for Q2 2025, and -$67.6 million during Q1 2025.